Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling

Hematology

Volumn 11, Issue 4, 2006, Pages 227-234

  El Chennawi, Farha A ^a   Kamel, Hosam A ^b   Mosaad, Youssef M ^a   El Sherbini, Sherif M ^c   El Billey, Nader A ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

^c MENOUFIA UNIVERSITY   (Egypt)

Author keywords

CD31 mismatch; Sibling donor; Stem cell transplant

Indexed keywords

BUSULFAN; CD31 ANTIGEN; CYCLOPHOSPHAMIDE; DNA; THYMOCYTE ANTIBODY; VINCRISTINE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CODON; CORRELATION ANALYSIS; DONOR; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; HEMATOLOGIC DISEASE; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; IMMUNOPATHOLOGY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT; RELAPSE; RISK FACTOR; STATISTICAL SIGNIFICANCE;

ABO BLOOD-GROUP SYSTEM; ACUTE DISEASE; ADOLESCENT; ADULT; ALLELES; ANTIGENS, CD31; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CODON; DNA; FEMALE; GENE FREQUENCY; GRAFT VS HOST DISEASE; HEMATOLOGIC DISEASES; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA ANTIGENS; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RISK FACTORS; SIBLINGS; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 33845706678     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1080/10245330600954189     Document Type: Article

References (22)

1. Behar, E and Chao, NJ and Hiraki, DD and (1996) Polymorphism of adhesion molecule CD31 and its role in acute graft-versus-host disease N Engl J Med, 334(5), pp. 286-291.
2. Nichlos, WC and Antin, JH and Lunetta, KL and (1996) Polymorphism of adhesion molecule CD31 is not a significant risk factor for graft-versus host disease Blood, 88(12), pp. 4429-4434.
3. Tseng, LH and Lin, MT and Hansen, JA and (1999) Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation Blood, 94, pp. 2911.
4. Gallardo, D and Arostegui, JI and Balas, A and (2001) Disparity for the minor histocompatibility antigens HA-1 is associated with an increased risk of acute graft-versus-host disease but it does not affect chronic GVHD incidence, disease-free survival or overall survival after allogeneic human leukocyte antigen-identical sibling donor transplantation Br J Haematol, 114, pp. 931.
5. van Els, CA and D'amaro, J and Pool, J and (1992) Immunogenetics of human minor histocompatibility antigens: Their polymorphism and immunodominance Immunogentics, 35, pp. 161.
6. Grumet, FC and Hiraki, DD and Brown, BW and (2001) CD31 mismatching affects marrow transplantation outcome Biol Blood Marrow Transplant, 7, pp. 503-512.
7. Maruya, E and Saji, H and Seki, S and (1998) Evidence that Cd3 1, Cd49b, and CD62l are immunodominant minor histocompatibility antigens in HLA identical sibling bone marrow transplants Blood, 92, pp. 2169.
8. Rozman, P and Karas, M and Kosir, A and (2003) Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation? Bone marrow Transplantation, 31, pp. 497.
9. Heinemann, FM and Ferencik, S and Ottinger, HD and (2004) Impact of Disparity of minor histocompatibility antigens HA-1, CD31 and Cd49b in hematopoeitic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors Transplantation, 77(7), pp. 1103-1106.
10. Parkhill, J and Wren, BW and Mungall, K and (2000) The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences Nature, 403, pp. 665-668.
11. Sullivan, K. (1994) Graft-versus-host disease. In Bone marrow transplantation. (pp. 339-362). Oxford, UK: Blackwell Scientific Publications.
12. Warren, EH and Greenberg, PD and Riddel, SR. (1998) Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution Blood, 91, pp. 2197-2207.
13. Wang, W and Meadows, LR and den Haan, JM and (1995) Human H-Y: A male-specific histocompatibility antigen derived from the SMCY protein Science, 269, pp. 1588-1590.
14. Goulmy, E and Schipper, R and Pool, J and (1996) Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation N Engl J Med, 334, pp. 281-285.
15. Cavanagh, G and Chapman, CE and Carter, V and (2005) Donor CD31 genotype impacts on transplant complications after human leukocyte antigen matched sibling allogeneic bone marrow transplantation Transplantation, 15(79(5)), pp. 602-605.
16. DaCosta, L and Charron, D and Loiseau, P. (1997) Does the adhesion molecule CD31 act as a minor histocompatibility antigen? Blood, 90, pp. 1332.
17. Glucksberg, H and Storb, R and Fefer, A and (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation, 18(4), pp. 295.
18. Balduinin, CL and Noris, P and Giorgiani, G and (1999) Incompatibility for CD31 and human platelet antigens and acute graft-versus-host disease after bone marrow transplantation Br J Haematol, 106, pp. 723-729.
19. Vicini, G and Masset, M and Semana, G and Vernant, JP. (1994) A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex Transplantation, 58, pp. 361-367.
20. den Haan, JMM and Sherman, NE and Blokland, E and Huczko, E and Koning, F and Drijfhout, JW and Skipper, J and Shabanowitz, J and Hunt, DF and Engelhard, VH and Goulmy, E. (1995) Identification of a graft versus host disease-associated human minor histocompatibility antigen Science, 268, pp. 1476.
21. DeLisser, HM and Newman, PJ and Albelda, SM. (1994) Molecular and functional aspects of PECAM-1/CD31 Immunol Today, 15, pp. 490.
22. Zehnder, JL and Shatsky, M and Leung, LLK and Butcher, EC and McGregor, JL and Levitt, LJ. (1995) Involvement of CD31 in lymphocyte-mediated immune responses: Importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptide Blood, 85, pp. 1282-1288.